Found: 56
Select item for more details and to access through your institution.
[ 111 In]In/[ 177 Lu]Lu-AAZTA 5 -LM4 SST 2 R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 776, doi. 10.3390/pharmaceutics15030776
- By:
- Publication type:
- Article
Head-to-Head Comparison of SSTR Antagonist [ 68 Ga]Ga-DATA 5m -LM4 with SSTR Agonist [ 68 Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 275, doi. 10.3390/ph17030275
- By:
- Publication type:
- Article
Head-to-Head Comparison between [ 68 Ga]Ga-DOTA.SA.FAPi and [ 18 F]F-FDG PET/CT Imaging in Patients with Breast Cancer.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 521, doi. 10.3390/ph16040521
- By:
- Publication type:
- Article
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [ 177 Lu]Lu-DOTA.SA.FAPi and [ 177 Lu]Lu-DOTAGA.(SA.FAPi) 2.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1212, doi. 10.3390/ph14121212
- By:
- Publication type:
- Article
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 11, p. e2120, doi. 10.1210/clinem/dgae024
- By:
- Publication type:
- Article
Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. e1670, doi. 10.1210/clinem/dgad343
- By:
- Publication type:
- Article
Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 6, p. e208, doi. 10.1210/clinem/dgac731
- By:
- Publication type:
- Article
Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo.
- Published in:
- Neuroradiology, 2022, v. 64, n. 5, p. 969, doi. 10.1007/s00234-021-02828-2
- By:
- Publication type:
- Article
Comparison of clinical outcome after a fixed dose versus dosimetry-based radioiodine treatment of Graves' disease: Results of a randomized controlled trial in Indian population.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2014, v. 18, n. 5, p. 648, doi. 10.4103/2230-8210.139222
- By:
- Publication type:
- Article
A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294343
- By:
- Publication type:
- Article
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>68</sup>Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer.
- Published in:
- Thyroid, 2023, v. 33, n. 8, p. 974, doi. 10.1089/thy.2023.0008
- By:
- Publication type:
- Article
Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years.
- Published in:
- Thyroid, 2022, v. 32, n. 10, p. 1220, doi. 10.1089/thy.2022.0234
- By:
- Publication type:
- Article
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study.
- Published in:
- Thyroid, 2022, v. 32, n. 1, p. 65, doi. 10.1089/thy.2021.0412
- By:
- Publication type:
- Article
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1889, doi. 10.3390/cancers15061889
- By:
- Publication type:
- Article
Long-term outcome of <sup>177</sup>Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0251375
- By:
- Publication type:
- Article
BRAF<sup>V600E</sup> and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2020, v. 33, n. 11, p. 1465, doi. 10.1515/jpem-2020-0174
- By:
- Publication type:
- Article
Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2015, v. 28, n. 7/8, p. 745, doi. 10.1515/jpem-2014-0247
- By:
- Publication type:
- Article
Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 7, p. 1031, doi. 10.1002/cam4.443
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00709-y
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00709-y
- By:
- Publication type:
- Article
Evaluation of bone-seeking novel radiotracer Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 1, p. 41, doi. 10.1007/s00259-016-3469-3
- By:
- Publication type:
- Article
Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 1, p. 81, doi. 10.1007/s00259-016-3481-7
- By:
- Publication type:
- Article
Reply to Rahbar K et al.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Radioiodine versus no radioiodine outcomes in low‐risk differentiated thyroid cancers: A propensity‐score matched analysis.
- Published in:
- Clinical Endocrinology, 2023, v. 99, n. 5, p. 483, doi. 10.1111/cen.14950
- By:
- Publication type:
- Article
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomas.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. 1, doi. 10.1186/s13550-019-0484-y
- By:
- Publication type:
- Article
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant <sup>225</sup>Ac-DOTATATE-Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 211, doi. 10.2967/jnumed.122.264043
- By:
- Publication type:
- Article
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant <sup>225</sup>Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264043
- By:
- Publication type:
- Article
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant <sup>225</sup>Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264043
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Head to head comparison of <sup>68</sup>Ga-NGUL and <sup>68</sup>Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258434
- By:
- Publication type:
- Article
Appropriateness of 14‐year cutoff in pediatric differentiated thyroid cancer: Comparison of clinical characteristics and long‐term outcomes in 14 years and younger and 15–18 years age groups.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30596
- By:
- Publication type:
- Article
Cytopathology of Solid Variant of Papillary Thyroid Carcinoma: Differential Diagnoses with other Thyroid Tumors.
- Published in:
- Acta Cytologica, 2018, v. 62, n. 5/6, p. 371, doi. 10.1159/000493081
- By:
- Publication type:
- Article
<sup>225</sup>Ac‐PSMA‐617‐targeted alpha therapy for the treatment of metastatic castration‐resistant prostate cancer: A systematic review and meta‐analysis.
- Published in:
- Prostate, 2021, v. 81, n. 9, p. 580, doi. 10.1002/pros.24137
- By:
- Publication type:
- Article
Tc-99m UBI Scintigraphy as a Cost-effective Alternative to Ga-68 NOTA-UBI PET/CT for Imaging Infections.
- Published in:
- Indian Journal of Nuclear Medicine, 2024, v. 39, n. 3, p. 237, doi. 10.4103/ijnm.ijnm_16_23
- By:
- Publication type:
- Article
Long-term clinicopathological features of a family with multiple endocrine neoplasia type 2A caused by C634R RET gene mutation.
- Published in:
- Indian Journal of Nuclear Medicine, 2020, v. 35, n. 1, p. 48, doi. 10.4103/ijnm.IJNM_168_19
- By:
- Publication type:
- Article
Coexistence of Multiple Metastatic Lesions Showing Various Grades of Differentiation in a Single Patient with Neuroendocrine Tumor of Lung as Primary: A Combined Modality Approach of <sup>68</sup>Ga-DOTANOC Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging
- Published in:
- Indian Journal of Nuclear Medicine, 2019, v. 34, n. 3, p. 260, doi. 10.4103/ijnm.IJNM_161_18
- By:
- Publication type:
- Article
Clinical Issues Related to Fluid Management during 177Lu-Peptide Receptor Radionuclide Therapy in Metastatic Neuroendocrine Tumors with Carcinoid Heart Disease.
- Published in:
- Indian Journal of Nuclear Medicine, 2018, v. 33, n. 4, p. 359, doi. 10.4103/ijnm.IJNM_83_18
- By:
- Publication type:
- Article
Estimation of Whole Body Radiation Exposure to Nuclear Medicine Personnel During Synthesis of <sup>177</sup>Lutetium-labeled Radiopharmaceuticals.
- Published in:
- Indian Journal of Nuclear Medicine, 2017, v. 32, n. 2, p. 89, doi. 10.4103/0972-3919.202245
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2495, doi. 10.1007/s00259-024-06677-y
- By:
- Publication type:
- Article
Therapeutic potential of [<sup>177</sup>Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 3, p. 805, doi. 10.1007/s00259-023-06482-z
- By:
- Publication type:
- Article
Head-to-head comparison of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi with [<sup>18</sup>F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 233, doi. 10.1007/s00259-023-06404-z
- By:
- Publication type:
- Article
Long-term survival outcomes of salvage [<sup>225</sup>Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3777, doi. 10.1007/s00259-023-06340-y
- By:
- Publication type:
- Article
Efficacy and safety of <sup>225</sup>Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 5, p. 1595, doi. 10.1007/s00259-021-05632-5
- By:
- Publication type:
- Article
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1915, doi. 10.1007/s00259-020-05132-y
- By:
- Publication type:
- Article